Indaptus Total Current Assets vs Total Assets Analysis

INDP Stock  USD 2.13  0.01  0.47%   
Indaptus Therapeutics financial indicator trend analysis is infinitely more than just investigating Indaptus Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Indaptus Therapeutics is a good investment. Please check the relationship between Indaptus Therapeutics Total Current Assets and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Total Current Assets vs Total Assets

Total Current Assets vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Indaptus Therapeutics Total Current Assets account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Indaptus Therapeutics' Total Current Assets and Total Assets is 0.92. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Total Assets in the same time period over historical financial statements of Indaptus Therapeutics, assuming nothing else is changed. The correlation between historical values of Indaptus Therapeutics' Total Current Assets and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Indaptus Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Current Assets i.e., Indaptus Therapeutics' Total Current Assets and Total Assets go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Total Assets

Total assets refers to the total amount of Indaptus Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Indaptus Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Indaptus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.As of 07/21/2024, Enterprise Value is likely to grow to about 1.7 M, while Selling General Administrative is likely to drop slightly above 5.3 M.
 2021 2022 2023 2024 (projected)
Interest Expense17.7K588.1K676.3K710.1K
Depreciation And Amortization1.4K1.8K1.3K1.2K

Indaptus Therapeutics fundamental ratios Correlations

-0.04-0.020.170.920.56-0.02-0.780.020.370.8-0.02-0.03-0.410.85-0.030.240.240.080.680.070.130.92-0.030.010.6
-0.041.00.98-0.42-0.771.00.43-0.990.91-0.391.00.990.86-0.551.0-0.81-0.350.81-0.740.990.98-0.421.01.0-0.77
-0.021.00.98-0.4-0.771.00.44-0.990.91-0.41.00.990.86-0.541.0-0.79-0.280.85-0.730.990.99-0.411.01.0-0.77
0.170.980.98-0.22-0.650.980.27-0.970.98-0.220.980.970.78-0.370.98-0.75-0.270.83-0.590.991.0-0.220.980.99-0.64
0.92-0.42-0.4-0.220.81-0.4-0.880.4-0.010.88-0.4-0.41-0.70.99-0.410.530.36-0.230.91-0.31-0.261.0-0.41-0.370.84
0.56-0.77-0.77-0.650.81-0.76-0.790.74-0.490.77-0.75-0.74-0.950.87-0.770.870.32-0.610.97-0.68-0.670.81-0.77-0.740.98
-0.021.01.00.98-0.4-0.760.42-0.990.92-0.381.00.990.86-0.541.0-0.79-0.310.84-0.730.990.99-0.41.01.0-0.76
-0.780.430.440.27-0.88-0.790.42-0.450.06-1.00.450.470.63-0.890.44-0.390.070.5-0.870.370.3-0.890.440.41-0.88
0.02-0.99-0.99-0.970.40.74-0.99-0.45-0.910.4-1.0-1.0-0.820.54-0.990.740.3-0.830.72-1.0-0.980.41-1.0-0.990.76
0.370.910.910.98-0.01-0.490.920.06-0.91-0.010.910.90.65-0.160.91-0.68-0.250.77-0.410.940.97-0.010.910.93-0.47
0.8-0.39-0.4-0.220.880.77-0.38-1.00.4-0.01-0.41-0.43-0.610.88-0.40.36-0.1-0.480.85-0.33-0.250.89-0.39-0.370.85
-0.021.01.00.98-0.4-0.751.00.45-1.00.91-0.411.00.83-0.541.0-0.76-0.290.84-0.730.990.98-0.411.01.0-0.77
-0.030.990.990.97-0.41-0.740.990.47-1.00.9-0.431.00.82-0.550.99-0.73-0.250.86-0.730.990.98-0.410.990.99-0.77
-0.410.860.860.78-0.7-0.950.860.63-0.820.65-0.610.830.82-0.780.87-0.93-0.380.67-0.910.780.79-0.70.860.84-0.91
0.85-0.55-0.54-0.370.990.87-0.54-0.890.54-0.160.88-0.54-0.55-0.78-0.550.610.37-0.360.96-0.46-0.40.99-0.55-0.520.91
-0.031.01.00.98-0.41-0.771.00.44-0.990.91-0.41.00.990.87-0.55-0.8-0.30.84-0.740.990.99-0.411.01.0-0.77
0.24-0.81-0.79-0.750.530.87-0.79-0.390.74-0.680.36-0.76-0.73-0.930.61-0.80.54-0.510.77-0.72-0.760.52-0.8-0.780.77
0.24-0.35-0.28-0.270.360.32-0.310.070.3-0.25-0.1-0.29-0.25-0.380.37-0.30.540.260.33-0.27-0.290.34-0.33-0.280.22
0.080.810.850.83-0.23-0.610.840.5-0.830.77-0.480.840.860.67-0.360.84-0.510.26-0.570.840.83-0.250.820.85-0.67
0.68-0.74-0.73-0.590.910.97-0.73-0.870.72-0.410.85-0.73-0.73-0.910.96-0.740.770.33-0.57-0.65-0.620.91-0.74-0.710.99
0.070.990.990.99-0.31-0.680.990.37-1.00.94-0.330.990.990.78-0.460.99-0.72-0.270.84-0.650.99-0.320.990.99-0.7
0.130.980.991.0-0.26-0.670.990.3-0.980.97-0.250.980.980.79-0.40.99-0.76-0.290.83-0.620.99-0.260.990.99-0.67
0.92-0.42-0.41-0.221.00.81-0.4-0.890.41-0.010.89-0.41-0.41-0.70.99-0.410.520.34-0.250.91-0.32-0.26-0.42-0.380.85
-0.031.01.00.98-0.41-0.771.00.44-1.00.91-0.391.00.990.86-0.551.0-0.8-0.330.82-0.740.990.99-0.421.0-0.78
0.011.01.00.99-0.37-0.741.00.41-0.990.93-0.371.00.990.84-0.521.0-0.78-0.280.85-0.710.990.99-0.381.0-0.75
0.6-0.77-0.77-0.640.840.98-0.76-0.880.76-0.470.85-0.77-0.77-0.910.91-0.770.770.22-0.670.99-0.7-0.670.85-0.78-0.75
Click cells to compare fundamentals

Indaptus Therapeutics Account Relationship Matchups

Pair Trading with Indaptus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Indaptus Stock

  0.62PDSB PDS Biotechnology CorpPairCorr
  0.4GILD Gilead SciencesPairCorr
  0.37MCRB Seres TherapeuticsPairCorr
  0.31JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.